Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

May 14, 2026

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

May 14, 2026

This map tracks data center projects and AI policy around the world

May 14, 2026

PruittHealth Certified as a Great Place to Work for Fifth Consecutive Year

May 14, 2026

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

May 14, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » Navigating Life with Hypertrophic Cardiomyopathy
Press Release

Navigating Life with Hypertrophic Cardiomyopathy

By News RoomMay 14, 20264 Mins Read
Navigating Life with Hypertrophic Cardiomyopathy
Share
Facebook Twitter LinkedIn Pinterest Email

NEW YORK, May 14, 2026 (GLOBE NEWSWIRE) — (Feature Impact) Living with obstructive or non-obstructive hypertrophic cardiomyopathy (HCM) can affect everyday life, your plans and the people around you. For some people, every morning with the condition can feel a bit like a “roll of the dice.”

Simple tasks like making the bed, climbing stairs or working at the computer can lead to breathlessness or an inability to focus. What may start as a “good day” can quickly lead to fatigue and thoughts that you “pushed too hard.”

HCM is a complex heart condition caused by abnormal genes that leads to thickening and stiffening of the heart muscle, requiring more energy for the heart to pump effectively. The condition, which can develop at any point in life, reduces the amount of oxygen-rich blood being pumped to the rest of the body, which leads to symptoms and potential complications, especially in those who develop the condition before age 40, according to research published in “Circulation,” the American Heart Association’s flagship journal.

To learn more about the condition, consider this information from the experts at Lexicon Pharmaceuticals, sponsors of the SONATA-HCM clinical trial studying a potential new treatment for HCM.

HCM Signs and Symptoms
Some people with HCM don’t have symptoms in the early stages but develop them over time. Particularly if you have a family history of HCM or the abnormal gene, beware of these common symptoms:

  • Feeling fatigued or lacking energy
  • Breathlessness, especially with physical activity
  • Chest discomfort or pain
  • Lightheadedness, fainting or dizziness
  • Swelling in the ankles, feet, legs or stomach

Potential HCM Complications
People living with HCM may develop further complications, such as heart failure, atrial fibrillation, ventricular tachycardia or ventricular fibrillation. The condition can also lead to sudden death, especially in children, teens, young adults and competitive athletes, who may not have any (or few) symptoms and are unaware they have a heart problem.

Common Risk Factors
HCM can run in families, and children of an affected parent have a 50% chance of having HCM, based on additional research published in “Circulation.” Other family members also have an increased risk of having HCM. To assess your risk, collect a family health history, noting family members who passed away suddenly, especially if they were 40 years old or younger; family members with heart failure, atrial fibrillation or other cardiac events such as heart attack or stroke; and family members who have had a heart transplant or use a pacemaker or implantable cardioverter-defibrillator.

Diagnosing HCM
Genetic testing is the first step to diagnosing HCM after experiencing symptoms. If the testing shows you (or a family member) have the genetic abnormality, it’s important to see a cardiologist to check your heart and confirm the diagnosis.

Living with HCM
Currently, no medications have been proven to prevent HCM or reduce the risk of death from the condition. If you have obstructive HCM, your health care provider may recommend a medication, such as a cardiac myosin inhibitor (CMI), that may improve the obstruction and reduce symptoms. Recommendations also could include regular monitoring to check for changes in the heart, light-to-moderate physical activity, surgery for severe cases, participation in clinical trials or lifestyle changes to control high blood pressure, sleep apnea and obesity. These conditions could increase your risk of developing complications of HCM.

Why Enrolling in a Clinical Trial Could Make a Difference
Nearly every treatment breakthrough begins with patients who choose to participate in research. By joining the SONATA-HCM study, you may help advance care for those living with HCM.

The global Phase 3 clinical trial is investigating whether sotagliflozin, a once-daily dual-action SGLT1 and SGLT2 (Sodium-Glucose Co-Transporter) inhibitor, can improve symptoms and daily functioning for people with HCM. Earlier studies published in the “New England Journal of Medicine” suggest it may lower the risk of heart failure events, heart attacks and strokes. Researchers are now assessing its potential benefits – including improving how heart cells handle sugar and salt and use energy more efficiently – for people living with obstructive and non-obstructive HCM.

To explore whether taking part in the study is right for you, visit SONATA-HCM.com.

Photo courtesy of Shutterstock

Michael French
[email protected]
https://editors.featureimpact.com/

About Feature Impact
Feature Impact is 4media group’s earned-first content solution for audience-ready storytelling at scale. Formerly Family Features, the editorial service delivers measurable earned media results and authentic consumer engagement through high-quality, topical and seasonally relevant multimedia content. Publicly-facing content is available at culinary.net and eLivingToday.com, with additional ready-to-publish resources for editors and journalists at editors.featureimpact.com. Learn more at featureimpact.com.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/9d59b27d-0b45-43ac-88a9-076aa2ae4998

Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

Senti Biosciences Holdings Announces Positive FDA RMAT Meeting on Registrational Clinical and CMC Strategy for SENTI-202 in Relapsed/Refractory AML, Along with Important Efficacy and Durability Updates on the SENTI-202 Clinical Program

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

PruittHealth Certified as a Great Place to Work for Fifth Consecutive Year

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

WPIC Marketing + Technologies Named One of Canada’s Best Managed Companies

Toll Brothers Announces Final Opportunity to Purchase a New Home at The Cove at Encinitas in Coastal Southern California

raddar to Become a Mass-Media Platform with National Scale and Local Precision

Blaze Pizza Celebrates National Pizza Party Day With $0 Delivery Fee Offer

Blank Rome Expands Construction, Infrastructure, and Energy Capabilities with Partner Justin N. Leonelli in Pittsburgh

Editors Picks

Easy Environmental Solutions & Terreplenish® Show Outstanding Yield Increases & Offer Alternative To Petroleum-Based Fertilizers

May 14, 2026

This map tracks data center projects and AI policy around the world

May 14, 2026

PruittHealth Certified as a Great Place to Work for Fifth Consecutive Year

May 14, 2026

AIM ImmunoTech Posts Virtual Investor Key Opinion Leader Segment Spotlighting Ampligen Breakthrough Data in Pancreatic Cancer

May 14, 2026

Latest News

WPIC Marketing + Technologies Named One of Canada’s Best Managed Companies

May 14, 2026

Toll Brothers Announces Final Opportunity to Purchase a New Home at The Cove at Encinitas in Coastal Southern California

May 14, 2026

raddar to Become a Mass-Media Platform with National Scale and Local Precision

May 14, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version